|
Market Closed -
Nyse
16:00:02 2026-02-17 EST
|
Pre-market
07:34:30
|
|
289.09 USD
|
-1.40%
|
 |
289.50 |
+0.14%
|
|
02-05 |
Mizuho Adjusts Price Target on UnitedHealth Group to $350 From $430, Maintains Outperform Rating
|
MT
| |
02-04 |
HSBC Adjusts Price Target on UnitedHealth Group to $255 From $280, Maintains Reduce Rating
|
MT
| |
02-02 |
Truist Cuts Price Target on UnitedHealth Group to $370 From $410, Keeps Buy Rating
|
MT
| |
02-02 |
JPMorgan Adjusts PT on UnitedHealth Group to $389 From $425, Maintains Overweight Rating
|
MT
| |
01-30 |
Wells Fargo Adjusts PT on UnitedHealth Group to $370 From $400, Maintains Overweight Rating
|
MT
| |
01-29 |
TD Cowen Adjusts UnitedHealth Group Price Target to $311 From $338, Maintains Hold Rating
|
MT
| |
01-29 |
Barclays Adjusts Price Target on UnitedHealth to $327 From $391, Maintains Overweight Rating
|
MT
| |
01-28 |
UnitedHealth's Long-Term EPS Growth Target Encouraging, but Concerns Remain, RBC Says
|
MT
| |
01-28 |
UnitedHealth Group's 2026 Outlook Steady as Medicare Advantage Rate Raises Uncertainty, Morgan Stanley Says
|
MT
| |
01-28 |
UBS Adjusts UnitedHealth Price Target to $410 From $430, Maintains Buy Rating
|
MT
| |
01-28 |
UnitedHealth Likely to Deliver 'Modest' Beats, Raises Through 2026; Earnings Upside in 2027 Now Uncertain, BofA Says
|
MT
| |
01-28 |
BofA Securities Adjusts Price Target on UnitedHealth Group to $315 From $360, Maintains Neutral Rating
|
MT
| |
01-28 |
RBC Cuts Price Target on UnitedHealth Group to $361 From $408, Keeps Outperform Rating
|
MT
| |
01-28 |
Morgan Stanley Adjusts PT on UnitedHealth Group to $375 From $409, Maintains Overweight Rating
|
MT
| |
01-28 |
Piper Sandler Adjusts PT on UnitedHealth Group to $396 From $417, Maintains Overweight Rating
|
MT
| |
01-28 |
Evercore ISI Adjusts PT on UnitedHealth Group to $350 From $400, Maintains Outperform Rating
|
MT
| |
01-28 |
Jefferies Adjusts Price Target on UnitedHealth Group to $340 From $418, Maintains Buy Rating
|
MT
| |
01-28 |
Goldman Sachs Adjusts Price Target on UnitedHealth Group to $400 From $421, Maintains Buy Rating
|
MT
| |
01-28 |
Oppenheimer Adjusts PT on UnitedHealth Group to $385 From $415, Maintains Outperform Rating
|
MT
| |
01-28 |
Deutsche Bank Adjusts Price Target on UnitedHealth Group to $304 From $333, Maintains Hold Rating
|
MT
| |
01-28 |
Bernstein Adjusts Price Target on UnitedHealth Group to $405 From $444, Maintains Outperform Rating
|
MT
| |
01-28 |
Leerink Partners Adjusts PT on UnitedHealth Group to $345 From $410, Maintains Outperform Rating
|
MT
| |
01-27 |
Piper Sandler Cuts Price Target on UnitedHealth Group to $396 From $417, Maintains Overweight Rating
|
MT
| |
01-23 |
UnitedHealth Group's Investor Sentiment to Continue Improving, Morgan Stanley Says
|
MT
| |
01-23 |
Morgan Stanley Trims Price Target on UnitedHealth Group to $409 From $411, Keeps Overweight Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
